Trial Information
Dimethylsulphoxide-Supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curretage - A 6 Year Clinical and Histological Evaluation.
Inclusion Criteria:
- histological verified bcc.
- one or two PDT treatments with treatment interval no longer than two weeks.
- lesion complete response three months after therapy.
Exclusion Criteria:
- pregnant.
- Gorlin's syndrome.
- morpheaform or pigmented bcc.
- histology older than one year.
- tumour infiltration more than four mm.
- previous PDT treated lesions.
Type of Study:
Observational
Study Design:
Additional Descriptors: Convenience Sample, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Eidi Christensen, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
St. Olav University Hospital, Trondheim
Authority:
Norway: Norwegian Social Science Data Services
Study ID:
EC-002
NCT ID:
NCT00218829
Start Date:
September 1997
Completion Date:
Related Keywords:
- Carcinoma, Basal Cell
- Photodynamic treatment
- Basal cell carcinoma
- DMSO
- Carcinoma
- Carcinoma, Basal Cell